These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 33115689)

  • 1. Romiplostim as Adjunctive Treatment of Refractory Amegakaryocytic Immune Thrombocytopenia in a Dog.
    Polydoros T; Ioannidi OM; Korsavvidis I; Stefanidis S; Antoniadis T; Mylonakis ME
    Top Companion Anim Med; 2021 Mar; 42():100488. PubMed ID: 33115689
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of 5 dogs with immune-mediated thrombocytopenia using Romiplostim.
    Kohn B; Bal G; Chirek A; Rehbein S; Salama A
    BMC Vet Res; 2016 Jun; 12():96. PubMed ID: 27283401
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Romiplostim for treatment of thrombocytopenia in dogs: A retrospective assessment and clinical outcomes.
    Ryu MO; Kim JK; An JH; Seo KW; Oh YI; Youn HY
    J Vet Intern Med; 2024; 38(4):2158-2164. PubMed ID: 39023218
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thrombopoietin receptor agonists in refractory immune thrombocytopenia: differential responses to eltrombopag and romiplostim: a case report and possible explanations.
    Aoki T; Harada Y; Matsubara E; Suzuki T; Oyama T; Kasai M; Uchida T; Ogura M
    J Clin Pharm Ther; 2012 Dec; 37(6):729-32. PubMed ID: 22583038
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Primary immune thrombocytopenia (ITP) treated with romiplostim in routine clinical practice: retrospective study from the United Kingdom ITP Registry.
    Doobaree IU; Newland A; McDonald V; Nandigam R; Mensah L; Leroy S; Seesaghur A; Patel H; Wetten S; Provan D
    Eur J Haematol; 2019 May; 102(5):416-423. PubMed ID: 30758874
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Successful switching from eltrombopag to romiplostim in a pediatric patient with refractory chronic ITP].
    Mori M; Kato M; Koh K; Hanada R
    Rinsho Ketsueki; 2015 May; 56(5):511-3. PubMed ID: 26062675
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Thrombopoietin Receptor Agonists: Eltrombopag and Romiplostim for the Treatment of Chronic Immune Thrombocytopenia Purpura.
    Atkinson K
    Clin J Oncol Nurs; 2019 Apr; 23(2):212-216. PubMed ID: 30880797
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of Romiplostim during pregnancy as a rescue therapy in primary immune thrombocytopenia: Literature review and case description.
    Rosa María RN; Laura RL; Ángeles PB; Laura LB
    Platelets; 2020; 31(3):403-406. PubMed ID: 31116059
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Romiplostim in chronic immune thrombocytopenic purpura.
    Cersosimo RJ
    Clin Ther; 2009 Sep; 31(9):1887-907. PubMed ID: 19843480
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Romiplostim therapy in children with unresponsive chronic immune thrombocytopenia.
    Mokhtar GM; Tantawy AA; El Sherif NH
    Platelets; 2012; 23(4):264-73. PubMed ID: 22471399
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Successful treatment of Immune Thrombocytopenic Purpura (ITP) with the thrombopoietin-mimetic romiplostim.
    Meletis J; Katsandris A; Raptis SD; Mantzourani M
    Med Sci Monit; 2010 Aug; 16(8):CS100-2. PubMed ID: 20671616
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Successful management of primary immune thrombocytopenia with romiplostim during open heart surgery in a hemodialysis patient].
    Nishikii H; Kurita N; Kusakabe M; Yokoyama Y; Kato T; Sakata-Yanagimoto M; Obara N; Hasegawa Y; Chiba S
    Rinsho Ketsueki; 2019; 60(1):28-32. PubMed ID: 30726820
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Romiplostim treatment for children with immune thrombocytopenia: Results of an integrated database of five clinical trials.
    Tarantino MD; Despotovic J; Roy J; Grainger J; Cooper N; Beam D; Raj A; Maschan A; Kim J; Eisen M
    Pediatr Blood Cancer; 2020 Nov; 67(11):e28630. PubMed ID: 32902132
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Romiplostim in children with chronic immune thrombocytopenia (ITP): the French experience.
    Pasquet M; Aladjidi N; Guiton C; Courcoux MF; Munzer M; Auvrignon A; Lutz P; Ducassou S; Leroy G; Munzer C; Leverger G;
    Br J Haematol; 2014 Jan; 164(2):266-71. PubMed ID: 24152194
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Response of refractory immune thrombocytopenia after bone marrow transplantation to romiplostim.
    Beck JC; Burke MJ; Tolar J
    Pediatr Blood Cancer; 2010 Mar; 54(3):490-1. PubMed ID: 19908296
    [No Abstract]   [Full Text] [Related]  

  • 16. Romiplostim in adults with newly diagnosed or persistent immune thrombocytopenia.
    Lozano ML; Godeau B; Grainger J; Matzdorff A; Rodeghiero F; Hippenmeyer J; Kuter DJ
    Expert Rev Hematol; 2020 Dec; 13(12):1319-1332. PubMed ID: 33249935
    [No Abstract]   [Full Text] [Related]  

  • 17. Effect of a thrombopoietin receptor agonist on use of intravenous immune globulin in patients with immune thrombocytopenia.
    Zeller MP; Heddle NM; Kelton JG; Hamilton K; Wang G; Sholapur N; Carruthers J; Hsia C; Blais N; Toltl L; Hamm C; Pearson MA; Arnold DM
    Transfusion; 2016 Jan; 56(1):73-9. PubMed ID: 26400824
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Successful early romiplostim use in a case of severe immune thrombocytopenia with critical carotid arterial injury.
    Watanabe R; Tabayashi T; Tomikawa T; Sagawa M; Anan-Nemoto T; Kimura Y; Takahashi Y; Tokuhira M; Otaki S; Oi H; Sawano M; Sugiyama S; Kizaki M
    Int J Hematol; 2017 Jan; 105(1):100-103. PubMed ID: 27709451
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Romiplostim in children with chronic refractory ITP: randomized placebo controlled study.
    Elalfy MS; Abdelmaksoud AA; Eltonbary KY
    Ann Hematol; 2011 Nov; 90(11):1341-4. PubMed ID: 21318572
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Romiplostim for Immune Thrombocytopenia in Neuroblastoma Patients Receiving Chemotherapy.
    Fassel H; Bussel JB; Roberts SS; Modak S
    J Pediatr Hematol Oncol; 2019 May; 41(4):e257-e259. PubMed ID: 29683946
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.